{"id":"https://openalex.org/W82579025","doi":null,"title":"Targeting cancer cells -- more pathways, more inhibitors, more trails. Highlights of 9th annual Drug Discovery Technology World Congress; August 8-13, 2004; Boston, Massachusetts.","display_name":"Targeting cancer cells -- more pathways, more inhibitors, more trails. Highlights of 9th annual Drug Discovery Technology World Congress; August 8-13, 2004; Boston, Massachusetts.","publication_year":2004,"publication_date":"2004-10-12","ids":{"openalex":"https://openalex.org/W82579025","mag":"82579025","pmid":"https://pubmed.ncbi.nlm.nih.gov/15775849","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1480574"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1480574","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1480574","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedGenMed","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1480574","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033363853","display_name":"Sara M Mariani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163728","display_name":"Medscape","ror":"https://ror.org/05xyx5995","country_code":"US","type":"other","lineage":["https://openalex.org/I4210163728"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sara M Mariani","raw_affiliation_strings":["Medscape General Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medscape General Medicine","institution_ids":["https://openalex.org/I4210163728"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5033363853"],"corresponding_institution_ids":["https://openalex.org/I4210163728"],"apc_list":null,"apc_paid":null,"fwci":0.0976,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.35503707,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"6","issue":"4","first_page":"22","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.49799999594688416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.49799999594688416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.41530001163482666,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.8199999928474426},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.6959999799728394},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/signaling-pathways","display_name":"signaling pathways","score":0.7929999828338623},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.996999979019165},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.9990000128746033},{"id":"https://openalex.org/keywords/histone-deacetylase","display_name":"histone deacetylase","score":0.9750000238418579},{"id":"https://openalex.org/keywords/aurora-kinases","display_name":"Aurora kinases","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8769999742507935},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8809999823570251},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.48899999260902405},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6108448505401611},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5466795563697815},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5052650570869446},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4695321321487427},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4656814932823181},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4625586271286011},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42605385184288025},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3825567662715912},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35563981533050537},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3482629954814911},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34401077032089233},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33721888065338135},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.30815058946609497},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.16189226508140564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15952950716018677},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09285414218902588}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:1480574","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1480574","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedGenMed","raw_type":"Text"},{"id":"pmid:15775849","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15775849","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedGenMed : Medscape general medicine","raw_type":"Conference Proceedings"},{"id":"mag:82579025","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15775849","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1480574","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1480574","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedGenMed","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4285192292","https://openalex.org/W2204493619","https://openalex.org/W1980138637","https://openalex.org/W2316147188","https://openalex.org/W4408977770","https://openalex.org/W1972941606","https://openalex.org/W2962354828","https://openalex.org/W4305015474","https://openalex.org/W7100685670","https://openalex.org/W2077804275"],"abstract_inverted_index":{"Although":[0],"some":[1],"may":[2],"be":[3,187],"a":[4,149],"bit":[5],"puzzled":[6],"by":[7,25,99],"the":[8,21,28,34,67,78,84,87,103,161,164,170,188],"ever-increasing":[9],"number":[10],"of":[11,31,37,55,122,144,163,197,215],"small":[12,166],"molecular":[13,167],"inhibitors":[14,54,116,168],"being":[15],"tested":[16],"for":[17,50,69,120,193],"their":[18,70,137,191,221],"anticancer":[19,157],"activity,":[20,32,174,208],"limited":[22],"efficacy":[23],"shown":[24],"available":[26,119],"compounds,":[27],"restricted":[29],"range":[30],"or":[33,62],"significant":[35],"rate":[36],"resistance":[38],"development":[39],"is":[40,135],"prompting":[41],"researchers":[42],"in":[43,74,113,129,132,169],"academic":[44],"and":[45,52,58,93,126,131,139,182,200,223],"industrial":[46],"laboratories":[47],"to":[48,204,220],"look":[49],"more":[51],"better":[53],"cancer":[56,75,194],"growth":[57,80],"survival.\r\n\r\nMultiple":[59],"signaling":[60,124],"pathways":[61,125],"intracellular":[63],"compartments":[64],"are":[65,117,180],"under":[66],"microscope":[68],"potential":[71],"therapeutic":[72],"relevance":[73],"treatment":[76],"--":[77,96],"insulin":[79],"factor":[81],"pathway":[82],"(IGF),":[83],"mTOR":[85],"pathway,":[86],"ubiquitin-proteasome":[88],"system,":[89],"histone":[90],"deacetylases":[91],"(HDACs),":[92],"Aurora":[94],"kinases":[95],"as":[97,209,211],"illustrated":[98],"lead":[100],"investigators":[101],"at":[102],"9th":[104],"Annual":[105],"Drug":[106],"Discovery":[107],"Technology":[108],"World":[109],"Congress,":[110],"recently":[111],"held":[112],"Boston,":[114],"Massachusetts.\r\n\r\nTargeted":[115],"now":[118],"most":[121],"these":[123],"systems.":[127],"Multiple":[128],"vitro":[130],"vivo":[133],"testing":[134],"unveiling":[136],"characteristics":[138],"will":[140,146,185,218],"ultimately":[141,186],"determine":[142],"which":[143],"them":[145],"indeed":[147],"represent":[148],"viable":[150],"strategy":[151],"that":[152],"meaningfully":[153],"improves":[154],"on":[155],"current":[156],"treatments.\r\n\r\nAs":[158],"learned":[159],"from":[160],"introduction":[162],"first":[165],"past":[171],"few":[172],"years,":[173],"safety,":[175],"tolerability":[176],"(if":[177],"long-term":[178],"treatments":[179],"envisioned),":[181],"cost-benefit":[183],"ratios":[184],"parameters":[189],"determining":[190],"success":[192],"patients.":[195],"Identification":[196],"specific":[198],"biomarkers":[199],"clinical":[201,224],"end":[202],"points":[203],"measure":[205],"relative":[206],"antitumor":[207],"well":[210],"an":[212],"accurate":[213],"selection":[214],"responsive":[216],"patients,":[217],"add":[219],"applicability":[222],"use.":[225]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}